Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. USO
6. TSLA
7. AMD
8. META
9. AMC
10. COHR

Go back to Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix

TD Cowen Downgrades Edwards Lifesciences (EW) to Hold

July 25, 2024 7:17 AM EDT

TD Cowen analyst Joshua Jennings downgraded Edwards Lifesciences (NYSE: EW) from Buy to Hold with a price target of $70.00 (from $100.00).

The analyst comments "We are downgrading EW to Hold as we are now forecasting HSD revenue growth in 2024 and 2025 due to... More

Edwards Lifesciences (EW) PT Lowered to $85 at RBC Capital

July 25, 2024 6:32 AM EDT

RBC Capital analyst Shagun Singh lowered the price target on Edwards Lifesciences (NYSE: EW) to $85.00 (from $101.00) while maintaining a Outperform rating.

The analyst comments "EW delivered Q2'24 results missing sales expectations and lowering 2024 operational revenue growth outlook to 8-10%... More

Edwards Lifesciences (EW) PT Lowered to $76 at Evercore ISI

July 25, 2024 4:59 AM EDT

Evercore ISI analyst Vijay Kumar lowered the price target on Edwards Lifesciences (NYSE: EW) to $76.00 (from $91.00) while maintaining a In Line rating.

The analyst comments "Thesis Update: This was tough call for EWthe rev miss, low quality EPS (~5c aid from discrete... More